Sigma-Aldrich Posts 13-Percent Increase in Q2 Sales Amid Rise in R&D and Profit | GenomeWeb
NEW YORK (GenomeWeb News) — Sigma-Aldrich yesterday said second-quarter revenue increased 13 percent as R&D spending rose 8 percent and profit climbed 13 percent.
Total receipts for the three months ended June 30 increased to $508 million from $449 million year over year.
R&D spending increased to $14.5 million from $13.4 million year over year.
The company said profit increased to $79.7 million from $70.3 million in the year-ago period. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.